Noticias y Actividades de Protagen

Protagen pertenece a Oncimmune. Oncimmune tiene presencia directa en 2 países.

Ver el organigrama con sus 7 ejecutivos principales

Biografías más buscadas en Protagen

• Roland Moussa, President, EU
• Tina Gerhards, Vice President, Quality Management
• André Abts, Vice President, Project Management Chemistry, Manufac...

Recientes movimientos de ejecutivos en Oncimmune

• Martin Hudson, Chief Financial Officer, ha dejado la empresa  (noticia publicada el 10 de junio de 2026).

Crear su alerta
para seguir los movimientos de los ejecutivos en Protagen.

Oncimmune tiene 2.428 competidores entre los que se incluyen Lonza (Suiza), Vertex Pharmaceuticals (Estados Unidos) y Eurofins (Luxemburgo).

Popular M&A news in Biotecnología

• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado el 17 de julio de 2026).
• GSK ha Nuvalent adquirido (publicado el 17 de julio de 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (publicado el 15 de julio de 2026).

Otros contactos sugeridos en el sector Biotecnología

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer en Inceptive
• Jan Van de Winkel - President and Chief Executive Officer en Genmab
• Patrick Enright - Director en CuraSen Therapeutics

Saber más sobre el sector Biotecnología

Últimos comunicados de prensa de Protagen

• Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene
• Protagen Protein Services (PPS) expands analytical Service Spectrum in Biotherapeutical Development Support
• Mass spectrometry in cell and gene therapy development projects – a versatile tool for CGT in-depth studies
• Protagen Protein Service Merge with Panatecs
• Our latest mAbs publication: Host cell protein detection gap risk mitigation: quantitative IAC-MS for ELISA antibody reagent coverage determination
• Protagen AG sells Service Business
• Protagen Protein Services Merges with GeneWerk to Integrate Leading Protein and Gene Therapy Analytic Platforms | Protagen
• New brochure "CELL AND GENE THERAPY - ANALYTICAL SERVICES FOR VIRAL DELIVERY SYSTEMS" is now available | Protagen
• ADVANCED MS APPROACHES FOR THE CHARACTERIZATION OF ADC HETEROGENEITY AND STABILITY | Protagen
• Our new Application Note: Advanced MS Approaches for the Characterization of ADC Heterogenity and Stability | Protagen
• View more press releases Close

Redes sociales sobre Protagen

• Protagen en Wikipedia, Google News y Yahoo Finance
• Protagen en LinkedIn, Twitter y YouTube